Edition:
India

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,483.50GBp
25 Apr 2019
Change (% chg)

13.50 (+0.92%)
Prev Close
1,470.00
Open
1,475.00
Day's High
1,483.50
Day's Low
1,463.50
Volume
3,540,298
Avg. Vol
2,231,194
52-wk High
1,548.50
52-wk Low
1,242.50

Select another date:

Wed, Mar 13 2019

Deals of the day-Mergers and acquisitions

March 12 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

Britain's Smith & Nephew to buy Osiris in regenerative products push

Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as the British medical products maker looks to bulk up in an area that is quickly growing.

UPDATE 1-Britain's Smith & Nephew to buy Osiris in regenerative products push

March 12 Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as the British medical products maker looks to bulk up in an area that is quickly growing.

Smith & Nephew to buy Osiris Therapeutics for $660 mln

March 12 British medical products maker Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as it looks to boost profit margins and find new sources of growth.

Smith & Nephew in talks to buy NuVasive for over $3 billion: FT

Britain's Smith & Nephew Plc has held talks to buy U.S. medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

UPDATE 2-Smith & Nephew in talks to buy NuVasive for over $3 bln - FT

Feb 8 Britain's Smith & Nephew Plc has held talks to buy U.S. medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

UPDATE 1-Smith & Nephew in talks to buy NuVasive for over $3 bln - FT

Feb 8 Britain's Smith & Nephew Plc has held talks to buy U.S.-based medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

Smith & Nephew in talks to buy NuVasive for over $3 bln - FT

Feb 8 Britain's Smith & Nephew Plc has held talks to buy U.S.-based medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

CORRECTED-UPDATE 1-Emerging markets to fuel Smith & Nephew revenue growth in 2019

Feb 7 British medical products maker Smith & Nephew forecast full-year revenue growth in line with analysts' expectations on Thursday, as it looks to grow in emerging markets and expand its product line-up.

Smith & Nephew misses on Q4 revenue as developed markets slow

Feb 7 British medical products maker Smith & Nephew fell short of analysts' expectations for fourth-quarter revenue on Thursday, as growth in established markets including the United States slowed and the company was hurt by a stronger dollar.

Select another date: